Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
Prenalterol, a beta1 agonist, was given in a single blind acute intravenous study to seven patients with cardiac failure (New York Heart Association class II and III). It was then given in a double blind crossover study of sustained oral prenalterol to six of them. As a result of dose titration stud...
Guardat en:
| Publicat a: | Br Heart J |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1984
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481544/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6326784/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.51.5.530 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|